Navigation Links
New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI
Date:6/17/2008

ical testosterone gel approved in 2000 for replacement therapy in men ages 18 and older for conditions associated with a deficiency or absence of endogenous testosterone. AndroGel is the most prescribed form of testosterone therapy for adult males in the United States.

Pivotal data showed that AndroGel was effective in restoring testosterone levels to normal and in some cases, superior to a transdermal testosterone patch.

-- AndroGel was effective in improving sexual function, mood, and muscle

strength; increasing lean body mass; and decreasing body fat.

-- It was demonstrated that AndroGel was more effective than a

testosterone patch in increasing lean body mass and decreasing body

fat, and had comparable effects with other symptoms.

-- Because of minimal skin irritation, subjects using AndroGel also had

higher compliance rates.

-- In a 2004 open-label, follow-up extension study, AndroGel was shown to

be safe for men to use over the long term.

The AndroGel pump is designed to deliver 1.25 grams of testosterone gel per pump depression, and it is also available in 2.5 and 5 gram packets. This gives patients two convenient ways to use AndroGel and offers physicians added flexibility to move, if necessary, from the starting dose of 5g per day to 7.5g or from 7.5g to 10g per day.

AndroGel must not be used if you have known or suspected prostate cancer or breast cancer (a rare condition for men). AndroGel must not be used by women who are pregnant, may become pregnant, or breastfeeding, as testosterone may cause fetal harm. The major risks of AndroGel include prostate enlargement, prostate cancer, and transfer of testosterone to others (including women and children). Transference can occur when vigorous skin-to- skin contact is made with the application site and can be minimized by washing your hands after application and covering the application site with clothing.

T
'/>"/>

SOURCE Solvay Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer
2. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
3. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
4. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
5. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
6. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
7. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
8. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
9. AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
10. Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Disease In Lung Transplant Recipients
11. Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Cardiac Defibrillators - A Worldwide Ma...linker.com/p0164315/Cardiac-Defibrillators---A-Wor...diovascular disease (CVD) is one of the foremost c...urvivors are prone to arrhythmic disorders, callin...
(Date:11/30/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Europe Ophthalmic Devices Investment Opp... http://www.reportlinker.com/p0166515/Europe-Ophth...d-Forecasts-to-2015.html ,, Europe Ophthalmic ...ecasts to 2015 ,, Summary ,, This report i...
(Date:11/30/2009)...PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: ...clinical documentation services, is featuring a ne...f North America (RSNA) conference in Chicago. Cal...ages SpeechQ(TM), the company,s real-time interact...ds of radiologists. MedQuist has integrated Speec...
Breaking Medicine Technology:Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2Independence Blue Cross Appoints Lauren OBrien Vice President Chief Accounting Officer 61519 1Independence Blue Cross Appoints Lauren OBrien Vice President Chief Accounting Officer 61519 2Arigene Co Ltd Enters Into Amendment To Merger Agreement With Trimeris Inc 6340 1Arigene Co Ltd Enters Into Amendment To Merger Agreement With Trimeris Inc 6340 2Arigene Co Ltd Enters Into Amendment To Merger Agreement With Trimeris Inc 6340 3Arigene Co Ltd Enters Into Amendment To Merger Agreement With Trimeris Inc 6340 4FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets 6337 1FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets 6337 2FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets 6337 3FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets 6337 4
...EAL, Aug. 20 Enobia Pharma, an emerging biotech,c...r serious bone,disorders, today announced that the...sphatasia has been dosed. Enobia is investigating ... the treatment of this rare and,often crippling ge...,treatment., Under two separate protocols, ENB-00...
...OLIS, Md., Aug. 20 Do you currently have a study,...given your sites,recruitment tools and a budget fo...s? Perhaps what you need is an extra set of hands ...cements and provide additional,administrative assi...Assist(TM) service," says Ms. Ann Kottcamp,Preside...
Other Medicine Technology:Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 2Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 3Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 2
(Date:11/30/2009)...0 Kool Smiles received top honor...nal recognition as one of InfoWorld ,s Top 100...itect, Mark Blomquist, Kool Smiles built a Wyse-ba...tronic health records systems at 13 new dental off... now complete, Kool Smiles has implemented electro...
(Date:11/30/2009).... 30 A revolutionary new technolog..., and patients with seamless, real-time access to ...of a button was announced today by Candelis, Inc.,...agement, visualization and workflow optimization t... with the cumbersome and costly method of sharing ...
(Date:11/30/2009)...equivalent to 113 chest X-rays, study finds , ...han half of patients who have abdominal/pelvic CT ... that expose them to extra radiation, U.S. researc...pelvic series were performed on 500 patients aged ... to 50 years of age. The researchers concluded tha...
(Date:11/30/2009)...ck, the unique online and mobile tool empowers pat...ment decisions ,, ARLINGTON, Va., Nov. 30 /P... ), the #1 HIV/AIDS resource online, today launche...ering HIV/AIDS-infected patients the ability to sa..., created with sponsorship from Merck, is availabl...
(Date:11/30/2009)...erland, Nov. 30 Tyco Int...t its 2010 annual general meeting of shareholders ...p.m. Central European time at the Park Hyatt Zuric...rland. Registered shareholders as of January 11, 2...the annual general meeting. Additionally, individ...
Breaking Medicine News(10 mins):Health News:Kool Smiles Named Among 2009 InfoWorld 100 2Health News:Candelis Announces Revolutionary Cloud-Hosted Data Services 2Health News:Candelis Announces Revolutionary Cloud-Hosted Data Services 3Health News:CT Scan Patients May Get Unnecessary Imaging 2Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2
...n the US have developed a breakthrough in the diag... the breath of a patient to reveal presence of bre...niversity scientists works by using switchable sur...Daily Mail. The user is then alerted to the pr...
... are on a stroll and you bump into a grey-haired m... 'hello, Mr. Clinton…', Your day// is made, no dou...bility of instant facial recognition ? Neurobiolog...ic also suggested that there may even be particula...
...logists and three other scientists will receive Th...ost coveted awards in science, for their exemplary...he awards will be presented on October 26, in Toro...h major ramifications for cancer, nutrition, auto-...
...demanded that the television commercials for ‘Head...dandruff free efficacy of their products, is requi...ool menthol varieties of the shampoo are the ones ...speaks of a 100% flakes claim, not apparent from a...
...y known to us that some popular spices might slow ...an assistant professor of obstetrics// and gynecol...ncer Center, and colleagues tested ginger powder d... study was done using cells in a lab dish, which i...
...overseas doctors in Britain are alarmed as new ru...ire work permit before they can work// in hospital...re are currently thousands of doctors from the In...erence will be given to the European Union (EU) do...
Other Medicine News:Health News:The Brain behind Facial Recognition 2Health News:The Brain behind Facial Recognition 3Health News:Spices Could Be Employed To Treat Certain Cancers 2Health News:Work Permit Required For Indian Doctors in Britain 2Health News:Work Permit Required For Indian Doctors in Britain 3
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: